LOC645023 Inhibitors
LOC645023 inhibitors can include LY294002 and Rapamycin can disrupt the PI3K/Akt/mTOR signaling axis, which plays a key role in cell growth and survival, potentially impacting the activity of LOC645023 if it is part of this pathway. Staurosporine and PD98059 offer a broader approach by inhibiting kinases that could phosphorylate LOC645023, thus affecting its activity and stability. Thapsigargin and Ionomycin exert their effects by manipulating intracellular calcium levels, thus influencing calcium-dependent regulatory mechanisms that LOC645023 may be subject to.
Chloroquine and MG132 can prevent the normal turnover and degradation of proteins, including LOC645023, by inhibiting autophagosome-lysosome fusion and proteasome activity, respectively. SB431542 and U0126 can interfere with TGF-beta and MAPK/ERK signaling, pathways that could be crucial for LOC645023's role in the cell. KN-93's inhibition of CaMKII affects calcium signaling, which may be relevant if LOC645023 is regulated by calcium-dependent processes. Lastly, 2-DG inhibits glycolysis, potentially affecting the energy metabolism necessary for LOC645023's function or expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which can alter the Akt signaling pathway potentially involved in LOC645023 regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds mTOR and can inhibit its pathway, which can affect processes regulating LOC645023. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Kinase inhibitor, can broadly inhibit protein kinases that may phosphorylate LOC645023. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which can affect the MAPK/ERK pathway and potentially the function of LOC645023. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis, which can affect calcium-dependent regulation of LOC645023. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Modulates autophagy by inhibiting lysosome acidification, which can affect LOC645023 degradation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, can prevent degradation of proteins including potentially LOC645023. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-beta receptor, which can affect signaling pathways involving LOC645023. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, which can modulate calcium signaling pathways that regulate LOC645023. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, which can disrupt calcium-dependent processes involving LOC645023. | ||||||